What's New
-
2025-05-27
(27 May 2025, Hong Kong) The HKSH Medical Group (HKSH) has for over a century been committed to acquiring the state-of-the-art, world-class technology and facilities to deliver excellent and advanced medical services. Mr. Wyman LI, Chief Operating Officer of HKSH Medical Group, Director of Hong Kong Sanatorium & Hospital, and Governor of The Li Shu Fan Medical Foundation,... -
2025-05-20
(20 May 2025, Hong Kong) Precision cancer treatment is based on accurate pathological diagnosis and cancer type classification. Harnessing advanced technologies and professional expertise at both genetic and chromosomal levels, The HKSH Cancer Centre (HKSH) is currently the only private medical institution in Hong Kong that offers comprehensive cancer genomic testing. By... -
2025-05-06
(6 May 2025, Hong Kong) The HKSH Medical Group (HKSH) is committed to expanding its crossborder diagnosis and treatment services. Following the launch of pioneering patient's case and rehabilitation planning consultation services in collaboration with FWD Hong Kong (FWD) in 2020, which includes free second medical opinion consultations, personalised case planning consultation... -
2025-04-29
(29 April 2025, Hong Kong) HKSH Medical Group (HKSH) is pleased to announce the generous donation of the revolutionary Histotripsy 2.0 system by the Li Ka Shing Foundation (LKSF). This innovative, non-invasive liver cancer treatment, utilising high-intensity focused ultrasound to precisely target liver tumours, enhances HKSH’s established capabilities in liver cancer care,...
